Skip to content

Anti-Thymocyte Globulin (Rabbit)

DRUG16 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), University of Nebraska, St. Jude Children's Research Hospital, McMaster University, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Acute LeukemiaAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Acute Myeloid Leukemia (AML)Aplastic AnemiaBone Marrow Failure SyndromeBone Marrow TransplantChronic Graft-versus-host-disease

Phase 1

Phase 2

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
CompletedNCT00260689
National Heart, Lung, and Blood Institute (NHLBI)Immunosuppresion, Neutropenia, Pancytopenia +1
Start: 2005-11-28End: 2016-05-04Updated: 2017-06-08
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
CompletedNCT00566696
St. Jude Children's Research HospitalHemoglobinuria, Paroxysmal Nocturnal (PNH), Hodgkin Lymphoma, Juvenile Myelomonocytic Leukemia (JMML) +5
Start: 2007-12-14End: 2020-02-06Updated: 2020-04-14
Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
TerminatedNCT01790594
National Institute of Allergy and Infectious Diseases (NIAID)Simultaneous Kidney and Pancreas Transplantation
Start: 2013-02-28End: 2016-08-31Updated: 2021-07-20
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
Active, not recruitingNCT01810588
Weill Medical College of Cornell UniversityHematologic Malignancies
Start: 2012-10-16End: 2028-04-30Updated: 2025-09-02
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
TerminatedNCT01856257
National Institute of Allergy and Infectious Diseases (NIAID)Kidney Transplantation, Primary Renal Allograft Candidate
Start: 2013-07-31End: 2016-04-30Updated: 2020-12-17
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Active, not recruitingNCT02790515
St. Jude Children's Research HospitalAcute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) +4
Start: 2016-07-14End: 2026-07-01Updated: 2025-08-12
A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
TerminatedNCT03600909
Memorial Sloan Kettering Cancer CenterAcute Myelogenous Leukemia (AML), Fanconi Anemia, Myelodysplastic Syndrome (MDS)
Start: 2018-05-15End: 2021-04-09Updated: 2022-04-12
ATG Plus PTCy vs ATG for CGVHD Prophylaxis
Active, not recruitingNCT04202835
McMaster UniversityAcute Leukemia, Chronic Graft-versus-host-disease, Myelodysplasia
Start: 2020-10-14End: 2026-02-07Target: 80Updated: 2025-05-11
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
Active, not recruitingNCT04395222
Weill Medical College of Cornell UniversityBone Marrow Transplant, Hematologic Malignancy
Start: 2020-10-07End: 2027-06-30Updated: 2026-01-06
Haploidentical HCT for Severe Aplastic Anemia
RecruitingNCT04558736
St. Jude Children's Research HospitalAplastic Anemia, Bone Marrow Failure Syndrome
Start: 2021-01-21End: 2030-07-01Target: 21Updated: 2025-07-04

Phase 3

Phase 4

Unknown Phase

Related Papers